Department store chain Kohl’s reports second-quarter results that narrowly misses analysts’ expectations, Amgen’s acquisition of Onyx Pharmaceuticals stalls on European approval on Onyx’s blood cancer treatment, and two former JP Morgan Chase employees are charged in the London whale case. TheStreet’s Brittany Umar reports in Ahead of the Ticker.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
